Fig. 1From: Different clinical significance of FGFR1–4 expression between diffuse-type and intestinal-type gastric cancerImmunostaining for fibroblast growth factor receptor (FGFR)1, FGFR2, FGFR3, and FGFR4. Representative primary gastric carcinomas exhibiting high expression for (a) FGFR1, (b) FGFR2, (c) FGFR3, and (d) FGFR4 in diffuse-type gastric cancer. Representative primary gastric carcinomas exhibiting high expression for (e) FGFR1, (f) FGFR2, (g) FGFR3, and (h) FGFR4 in intestinal-type gastric cancer. Magnification, ×400Back to article page